site stats

Regeneron historical stock price

WebJan 10, 2024 · The stock price of Regeneron has seen a 6% fall over the last twenty-one trading days, while it is down 7% over the last week. ... This historical pattern reflects 312 out of 516, ... Web102 rows · Discover historical prices for REGN stock on Yahoo Finance. View daily, weekly or monthly format back to when Regeneron Pharmaceuticals, Inc. stock was issued. Find out the direct holders, institutional holders and mutual fund holders for … See Regeneron Pharmaceuticals, Inc. (REGN) stock analyst estimates, … See Regeneron Pharmaceuticals, Inc. (REGN) Environment, Social and … Get the detailed quarterly/annual income statement for Regeneron … Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 … View the basic REGN option chain and compare options of Regeneron … Find out all the key statistics for Regeneron Pharmaceuticals, Inc. ... Get access to … Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock discussion in Yahoo …

13 U.S. health care stocks starting to shine again

WebApr 12, 2024 · 23 analysts have issued 1 year price objectives for Regeneron Pharmaceuticals' stock. Their REGN share price forecasts range from $625.00 to $1,040.00. On average, they predict the company's stock price to reach $840.57 in the next year. This suggests a possible upside of 1.4% from the stock's current price. View analysts price … WebView the latest Regeneron Pharmaceuticals Inc. (REGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. r60ant https://mondo-lirondo.com

Regeneron Pharmaceuticals Stock Quote. REGN - Stock Price, …

WebRegeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors. WebApr 6, 2024 · Price History & Performance. Summary of all time highs, changes and price drops for Regeneron Pharmaceuticals; Historical stock prices; Current Share Price: US$756.50: 52 Week High: US$772.50: 52 Week Low: US$524.70: Beta: 0.21: 1 Month Change: 2.62%: 3 Month Change: 8.09%: 1 Year Change: 14.03%: r600a refrigerant gas size

Regeneron Stock Price History for February - (USA Stocks:REGN ...

Category:Regeneron Pharmaceuticals, Inc. (REGN) Stock Price, Quote

Tags:Regeneron historical stock price

Regeneron historical stock price

Regeneron Pharmaceuticals, Inc. (REGN) Stock Price, Quote

WebApr 10, 2024 · Buy Regeneron Pharmaceuticals, Inc. Shares from India at $823.76 (0 Commission) today. Start investing in Regeneron Pharmaceuticals, Inc. stocks from India now with fractional investing only on INDmoneyapp WebGet the latest Regeneron Pharmaceuticals Inc (REGN) real-time quote, historical performance, charts, and other financial information to help you make more informed …

Regeneron historical stock price

Did you know?

WebApr 11, 2024 · Regeneron Announces Investor Conference Presentations. TARRYTOWN, N.Y., April 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. ( REGN) will webcast management participation as follows: BofA Securities 2024 Health Care Conference at 1:40 p.m. PT (4:40 p.m. ET) on Tuesday, May 9, 2024. 2024 RBC Capital … WebMar 31, 2024 · With Regeneron Pharmaceuticals stock trading at $821.67 per share, the total value of Regeneron Pharmaceuticals stock (market capitalization) is $89.83B. Regeneron Pharmaceuticals stock was originally listed at a price of $8.56 in Dec 31, 1997.

WebGet Regeneron Pharmaceuticals Inc (REGN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebGet the latest Amgen, Inc. (AMGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Web1 day ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Regeneron Pharmaceuticals (REGN) Web34 rows · Historical daily share price chart and data for Regeneron Pharmaceuticals since …

WebOct 28, 2024 · When it comes to market value, Regeneron Pharmaceuticals ( REGN 1.25%) may look like small potatoes compared to Amazon. The biotech company's market capitalization totals $61 billion. The e ...

WebLeonard (Len) Brooks joined Regeneron in 2013 and serves as senior vice president, treasurer. Mr. Brooks leads a team responsible for optimizing liquidity and use of capital resources, safeguarding Regeneron’s cash and investment portfolio, corporate risk management and maintaining strong relationships with financial institutions, insurance … shivaratri movies in teluguWebThe current price of REGN is $819.64. The 52 week high of REGN is $837.55 and 52 week low is $538.01. The next earnings date of Regeneron Pharmaceuticals Inc (REGN) is 2024-05-04. Subject. Date. shivaratri reasonWebApr 12, 2024 · Get the latest dividend data for Regeneron Pharmaceuticals, Inc. (REGN), including dividend history, yield, key dates, growth and other metrics. shivaratri song 2019 mangli mp3 downloadWebRegeneron Pharmaceuticals is selling at 748.08 as of the 22nd of February 2024; that is 0.21% increase since the beginning of the trading day. The stock's open price was 746.52. Get Regeneron Pharmaceuticals stock price history and adjusted historical data with charts, graphs, and statistical analysis. Regeneron Pharmaceuticals is United States Stock … shivaratri songs download mp3WebMar 3, 2024 · Regeneron Pharmaceuticals, Inc. Common Stock (REGN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. r60an ca0ach6WebBased on the Rule 16, the options market is currently suggesting that Regeneron Pharmaceuticals will have an average daily up or down price movement of about 4.91% per day over the life of the 2024-02-03 option contract. With Regeneron Pharmaceuticals trading at USD782.32, that is roughly USD38.42. r 600 mack gearboxes shift patternsWebShares of Regeneron jumped to new all-time highs following the successful phase 3 results of Dupixent in COPD. COPD could be a $3 billion or greater a year opportunity for Dupixent and should push its peak sales well above $20 billion by the end of the decade. r60an5a tv